More on GNFT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (3.3 Score)

Upcoming Events

- Earnings (2/23/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

GENFIT (NQ:GNFT)
Delayed: 4.85 --0 (-0%)
Prev. Close $4.85  
Open$4.85 
52 Wk High$ 
52 Wk Low$ 
Day High$4.85 
Day Low$4.85 
P/E N/A  
EPS$ 
Volume31,922 


Jan 7, 2026 12:00 PM GENFIT Announces 2026 Financial Calendar
Jan 6, 2026 12:12 PM GENFIT reports positive Phase 1 results for liver disease drug G1090N
Jan 6, 2026 12:12 PM GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N  
Nov 27, 2025 12:00 PM GENFIT appoints Dr. Pejvack Motlagh as chief medical officer
Nov 27, 2025 12:00 PM GENFIT Announces Appointment of new Chief Medical Officer
Sep 22, 2025 04:38 PM Genfit S.A. (GNFT) reports H1 results
Sep 22, 2025 04:10 PM GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update
Aug 19, 2025 06:12 AM H.C. Wainwright Assumes Genfit (GNFT) at Buy
View All Articles

Entities mentioned with GNFT

View All Entities